Clinical Trials Logo

Clinical Trial Summary

In this comparative study, the investigators aim to compare prospective pediatric patients who receive total lymphoid irradiation (TLI) using tomotherapy with age- and disease-matched controls who receive conventional total body irradiation (TBI) as part of conditioning for haploidentical hematopoietic stem cell transplantation (HSCT) for both malignant and non-malignant diseases. The investigators shall evaluate graft failure-free, graft-versus-host disease (GVHD)-free survival, overall survival, frequency of rejection, GVHD, relapse of malignancy, adverse effects and post-transplant immunoreconstitution.


Clinical Trial Description

Radiotherapy at a dose of 6Gy divided into 3 equal fractions (2Gy per fraction) to all lymphoid organs (TLI) over 2 days using tomotherapy will be given to participants as part of the conditioning treatment before haploidentical hematopoietic stem cell transplantation (HSCT). Retrospective patients who are age- and disease-matched with the recruited patients and had received radiotherapy to the whole body (TBI) with or without lung shielding at a total dose of 2-12 Gy delivered as 1-6 equal fractions by conventional opposed fields radiotherapy as part of conditioning will be compared for the outcomes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06075563
Study type Interventional
Source Hong Kong Children's Hospital
Contact Daniel Cheuk
Phone 852-35136049
Email cheukkld@gmail.com
Status Recruiting
Phase N/A
Start date May 29, 2023
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT06034535 - CD62L Depleted Donor Lymphocyte Infusion With T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation Phase 2
Completed NCT01010867 - Probiotic Use in Children Undergoing Hematopoietic Stem Cell Transplantation (HSCT) Phase 1